fashion -WSS

fashion

author：fashion 2025-09-03 03:39:01 - browse：21716

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Heart attack and stroke risk calculators need revising
Next article： No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Wikipedia

WSS

New study raises questions about niacin and heart health

Obamacare plans could cover weight loss drugs

Reporting on presidential health from Reagan to Trump and Biden

Plane’s emergency slide plummets from sky, hits Chicago home

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

New CMS data security rules will hurt Medicare, Medicaid research

hotspot

fashion

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Norman Reedus' Daryl Dixon

Guidelines to prevent youth baseball injuries need more muscle

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Novavax promises a turnaround & Lilly roils the obesity market

Norman Reedus' Daryl Dixon

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

A new drug could help frostbite victims avoid its ravages

Supreme Court strikes down use of affirmative action

Resistance to cancer drugs: A new genetic explanation

explore

WATCH: Why do our ears pop?

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Researchers tackle phage therapy hurdles for wider adoption

DOJ, FTC to increase scrutiny of all types of health care mergers

Why the Crimean Bridge is key to Russia's war in Ukraine

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

knowledge

leisure time

Wikipedia

hotspot